WEST FRONT STRATEGIES LLC for FRESENIUS KABI USA LLC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to drug pricing; issues related to pharmaceutical supply chain; issues related to FDA facility inspections, including HR 7006, Improving the Nations Safe Pharmaceuticals and Excipients by Creating Tools for Inspecting and Overseeing Needed Supplies Act or the INSPECTIONS Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ASHLEY DAVIS | — |
| CRAIG KALKUT | — |
| MALLOY MCDANIEL | — |
| KRISTI REMINGTON | — |
| SHIMON STEIN | — |
Copyright/Patent/Trademark CPT
Issues related to patent reform, including Restoring the America Invents Act, S. 2891.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ASHLEY DAVIS | — |
| CRAIG KALKUT | — |
| MALLOY MCDANIEL | — |
| KRISTI REMINGTON | — |
| SHIMON STEIN | — |
Medicare/Medicaid MMM
Formulary placement of generics and biosimilar biological products in Part D, including the Ensuring Access to Lower Cost Medicines for Seniors Act, H.R. 2846; issues related to access to biosimilar biological products in Medicare Part B, including the Increasing Access to Biosimilars Act of 2021, H.R. 2869 and S. 1427; issues related to rebate walls.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ASHLEY DAVIS | — |
| CRAIG KALKUT | — |
| MALLOY MCDANIEL | — |
| KRISTI REMINGTON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.